The present study aimed to determine the effects of the broad-spectrum matrix metalloproteinase and TACE-inhibitor Marimastat on hepatic steatosis and insulin resistance in murine models of diet-induced obesity and leptin deficiency. This evidence concerns the gene ADAM17 and Insulin resistance.